
Solana Company (HSDT) Stock Ticker
HSDT right now
Market factors today
Unlock the full HSDT picture
About Solana Company
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
HSDT stock facts
| Ticker symbol | HSDT |
| Exchange | NASDAQ Capital Market |
| Sector | Financial Services |
| Industry | Asset Management |
| Market cap | $171.7M |
| CEO | Dane Carl Andreeff |
| Employees | 21 |
| Headquarters | Newtown, PA, US |
| IPO date | 2014-06-27 |
| Website | www.solanacompany.co |
What you can see for HSDT on Tickr
Live HSDT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the HSDT report.
Rankings
FAQ
What is the ticker symbol for Solana Company?
The ticker symbol for Solana Company is HSDT, listed on the NASDAQ Capital Market.
What is HSDT?
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime…